Therefore, our study highlighted the critical contributions of loss of CDKN2A in the tumorigenesis and progression of lung cancer, which predominantly depended on downstream MTAP. Our study highlighted the antitumor properties of both CDKN2A and MTAP. This evidence concerns the gene CDKN2A and lung cancer.